about
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Con...
Read More
21.47
-0.79
(-3.55%)
142.9K
XNAS Volume
XNAS 15 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Neurogene Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..